首页 > 最新文献

Journal of cardiology & cardiovascular therapy最新文献

英文 中文
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Dilated Cardiomyopathy: A New Association? 慢性炎症性脱髓鞘性多神经病变(CIDP)与扩张型心肌病:一种新的关联?
Pub Date : 2018-10-09 DOI: 10.19080/jocct.2018.12.555838
V. M. Magro
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) belongs to the most common immune-mediated chronic disorders of the peripheral nervous system and intravenous immunoglobulin is considered the first-line treatment. in addition to being characterized by numerous phenotypic variants, this condition has been described as associated with other pathologies that have an immune pathogenesis. We describe the clinical case of a patient in whom this condition we discovered was associated with the presence of dilated cardiomyopathy. We tried to be learned from this clinical case report the implications, as well as clinics, even pathogenetic both on the CIDP pathogenesis and on cell-mediated and humoral mechanisms act synergistically to cause damage to cardiac muscle, to be able to derive a therapeutic approach that was optimal.
慢性炎症性脱髓鞘性多神经病(CIPD)属于最常见的免疫介导的外周神经系统慢性疾病,静脉注射免疫球蛋白被认为是一线治疗方法。除了具有许多表型变异的特征外,这种情况还被描述为与其他具有免疫发病机制的病理有关。我们描述了一名患者的临床病例,我们发现这种情况与扩张型心肌病的存在有关。我们试图从这份临床病例报告中了解CIDP发病机制以及细胞介导和体液机制协同作用对心肌损伤的影响,以及临床,甚至致病性,从而能够得出最佳的治疗方法。
{"title":"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Dilated Cardiomyopathy: A New Association?","authors":"V. M. Magro","doi":"10.19080/jocct.2018.12.555838","DOIUrl":"https://doi.org/10.19080/jocct.2018.12.555838","url":null,"abstract":"Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) belongs to the most common immune-mediated chronic disorders of the peripheral nervous system and intravenous immunoglobulin is considered the first-line treatment. in addition to being characterized by numerous phenotypic variants, this condition has been described as associated with other pathologies that have an immune pathogenesis. We describe the clinical case of a patient in whom this condition we discovered was associated with the presence of dilated cardiomyopathy. We tried to be learned from this clinical case report the implications, as well as clinics, even pathogenetic both on the CIDP pathogenesis and on cell-mediated and humoral mechanisms act synergistically to cause damage to cardiac muscle, to be able to derive a therapeutic approach that was optimal.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45622108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value on Surface Electrocardiogram for the Right Free Wall in Localizing Accessory Pathway by Simple Parameters in Typical Wolff-Parkinson-White Syndrome 典型Wolff-Parkinson-White综合征右游离壁表面心电图简单参数定位副通路的价值
Pub Date : 2018-09-27 DOI: 10.19080/jocct.2018.12.555836
Si Dung Chu
{"title":"Value on Surface Electrocardiogram for the Right Free Wall in Localizing Accessory Pathway by Simple Parameters in Typical Wolff-Parkinson-White Syndrome","authors":"Si Dung Chu","doi":"10.19080/jocct.2018.12.555836","DOIUrl":"https://doi.org/10.19080/jocct.2018.12.555836","url":null,"abstract":"","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43953951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery for A Sinus of Valsalva Aneurysm After Radical Repair of the Aortic Coarctation Complex in A Young Adult with Congenital Bicuspid Aortic Valve: A Case Report 先天性二尖瓣主动脉瓣年轻成人主动脉缩窄复合体根治性修复后主动脉窦瘤的手术治疗1例
Pub Date : 2018-09-25 DOI: 10.19080/jocct.2018.12.555835
Y. Kuroda
We describe a young adult who underwent surgery for sinus of Valsalva aneurysm and bicuspid aortic valve regurgitation, after undergoing radical repair of the aortic coarctation complex during childhood. A 22-year-old man had undergone radical repair for coarctation of the aorta and ventricular septal defect during childhood. He required surgical treatment of an enlarged ascending aorta and a sinus of Valsalva aneurysm with a congenital bicuspid aortic valve, as indicated using Computed Tomography (CT). Echocardiography revealed moderate regurgitation from the bicuspid aortic valve. We performed a repair of the sinus of Valsalva and replacement of the ascending aorta. Postoperatively, echocardiography revealed trivial aortic regurgitation, while CT indicated resolution of the enlarged ascending aorta and sinus of Valsalva aneurysm. The patient remains asymptomatic 1 year later. Valve sparing and aortic valve repair extensively benefit young patients exhibiting aortic root pathology following radical repair of congenital heart disease.
我们描述了一名年轻人,他在儿童时期接受了主动脉缩窄复合体的彻底修复后,接受了瓦尔萨尔瓦窦动脉瘤和双叶主动脉瓣反流的手术。一名22岁的男子在儿童时期接受了主动脉缩窄和室间隔缺损的根治性修复。如计算机断层扫描(CT)所示,他需要对升主动脉扩大和带有先天性二叶主动脉瓣的瓦尔萨尔瓦窦动脉瘤进行手术治疗。超声心动图显示二尖瓣有中度反流。我们进行了瓦尔萨尔瓦窦的修复和升主动脉的置换。术后,超声心动图显示轻微的主动脉反流,而CT显示升主动脉和瓦尔萨尔瓦窦瘤增大。患者在1年后仍无症状。保留瓣膜和主动脉瓣修复广泛受益于先天性心脏病根治性修复后出现主动脉根部病变的年轻患者。
{"title":"Surgery for A Sinus of Valsalva Aneurysm After Radical Repair of the Aortic Coarctation Complex in A Young Adult with Congenital Bicuspid Aortic Valve: A Case Report","authors":"Y. Kuroda","doi":"10.19080/jocct.2018.12.555835","DOIUrl":"https://doi.org/10.19080/jocct.2018.12.555835","url":null,"abstract":"We describe a young adult who underwent surgery for sinus of Valsalva aneurysm and bicuspid aortic valve regurgitation, after undergoing radical repair of the aortic coarctation complex during childhood. A 22-year-old man had undergone radical repair for coarctation of the aorta and ventricular septal defect during childhood. He required surgical treatment of an enlarged ascending aorta and a sinus of Valsalva aneurysm with a congenital bicuspid aortic valve, as indicated using Computed Tomography (CT). Echocardiography revealed moderate regurgitation from the bicuspid aortic valve. We performed a repair of the sinus of Valsalva and replacement of the ascending aorta. Postoperatively, echocardiography revealed trivial aortic regurgitation, while CT indicated resolution of the enlarged ascending aorta and sinus of Valsalva aneurysm. The patient remains asymptomatic 1 year later. Valve sparing and aortic valve repair extensively benefit young patients exhibiting aortic root pathology following radical repair of congenital heart disease.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49474898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiometabolic Diseases: A Global Perspective 心脏代谢疾病:全球视野
Pub Date : 2018-09-25 DOI: 10.19080/JOCCT.2018.12.555834
G. Rao
The George Institute for Global Health of Australia, in their website claim that the epidemic of cardio-metabolic diseases is escalating worldwide, including India. The rapid socioeconomic transition is believed to have contributed to this rise, with the individuals being increasingly exposed to energy-dense foods, high stress levels, and sedentary work habits. Larry Husten in an article in Lancet wrote, that in 1960, the typical heart-attack“victim” was a middle-class US or European executive. Cardiovascular Disease (CVD) was largely unknown in the developing world, but now, a global epidemic of CVD is underway. In the 21st century, say epidemiologists, a typical patient presenting with heart attack will be a Moscow Taxi driver, or a Bombay factory worker [1]. Underlying causes may or may not be the same at each demography. For instance, another article written in the same year, drew the attention of this prediction. Larry Husten contemplated on the enormous rise in deaths from heart disease in Russia. The author of this article points out to the fact, that to a large extent, the pattern of alcohol consumption may play a big role in the cardiovascular deaths in Russia [2]. Since 1980, incidence of obesity has increased by two-fold and diabetes by four-fold worldwide, according to the NCD Risk Factor Collaborators report [3,4]. Hypertension is one of the primary risk factors for heart disease and stroke. Over 875 million were hypertensives in the year 2000 and will double by the year 2025 [5]. Another factor to be considered when discussing from a global perspective, is that nearly two-thirds of individuals with CMDs live in lowand middle-income countries. On the other hand, immigrant population is increasing rapidly in several countries, because of the economic attractiveness and public infrastructure. Just look at the UAE as an example, they have more immigrants than the native Arabs. Although conventional cardiovascular risk factors such as smoking, blood pressure and total cholesterol predict risk within these ethnic groups, they do not fully account for the differences in risk, between ethnic groups, suggesting that alternative explanations might exist. We feel strongly, that there is a great need to investigate the prevalence and pattern of metabolic risks in general, identify the unique risk factors responsible for development and/or progression of these condition’s and the economic and social costs for the treatment of these diseases. All of these metabolic diseases have risen to the status of an epidemic, and cost of combating these diseases will pose, in the very near future, a great economic burden to the global community.
澳大利亚乔治全球健康研究所在其网站上声称,包括印度在内的全球心脏代谢疾病的流行正在升级。快速的社会经济转型被认为是导致这一增长的原因,人们越来越多地接触到高能量食物、高压力和久坐不动的工作习惯。Larry Husten在《柳叶刀》上的一篇文章中写道,1960年,典型的心脏病发作“受害者”是美国或欧洲的中产阶级高管。心血管疾病(CVD)在发展中国家基本上是未知的,但现在,CVD的全球流行正在进行。流行病学家说,在21世纪,典型的心脏病发作患者将是莫斯科出租车司机或孟买工厂工人[1]。在每个人口统计学中,根本原因可能相同,也可能不同。例如,同年写的另一篇文章引起了人们对这一预测的注意。拉里·胡斯滕(Larry Husten)对俄罗斯心脏病死亡人数的大幅上升进行了思考。本文作者指出,在很大程度上,饮酒模式可能在俄罗斯心血管死亡中发挥重要作用[2]。根据NCD风险因素合作者的报告[3,4],自1980年以来,全球范围内肥胖的发病率增加了两倍,糖尿病增加了四倍。高血压是心脏病和中风的主要危险因素之一。2000年,超过8.75亿人患有高血压,到2025年将翻一番[5]。从全球角度进行讨论时需要考虑的另一个因素是,近三分之二的CMD患者生活在中低收入国家。另一方面,由于经济吸引力和公共基础设施,一些国家的移民人口正在迅速增加。以阿联酋为例,他们的移民比土生土长的阿拉伯人多。尽管吸烟、血压和总胆固醇等传统心血管风险因素可以预测这些种族群体的风险,但它们并不能完全解释种族群体之间的风险差异,这表明可能存在其他解释。我们强烈认为,非常需要调查代谢风险的普遍性和模式,确定导致这些疾病发展和/或进展的独特风险因素,以及治疗这些疾病的经济和社会成本。所有这些代谢性疾病都已上升为流行病,在不久的将来,抗击这些疾病的成本将给全球社会带来巨大的经济负担。
{"title":"Cardiometabolic Diseases: A Global Perspective","authors":"G. Rao","doi":"10.19080/JOCCT.2018.12.555834","DOIUrl":"https://doi.org/10.19080/JOCCT.2018.12.555834","url":null,"abstract":"The George Institute for Global Health of Australia, in their website claim that the epidemic of cardio-metabolic diseases is escalating worldwide, including India. The rapid socioeconomic transition is believed to have contributed to this rise, with the individuals being increasingly exposed to energy-dense foods, high stress levels, and sedentary work habits. Larry Husten in an article in Lancet wrote, that in 1960, the typical heart-attack“victim” was a middle-class US or European executive. Cardiovascular Disease (CVD) was largely unknown in the developing world, but now, a global epidemic of CVD is underway. In the 21st century, say epidemiologists, a typical patient presenting with heart attack will be a Moscow Taxi driver, or a Bombay factory worker [1]. Underlying causes may or may not be the same at each demography. For instance, another article written in the same year, drew the attention of this prediction. Larry Husten contemplated on the enormous rise in deaths from heart disease in Russia. The author of this article points out to the fact, that to a large extent, the pattern of alcohol consumption may play a big role in the cardiovascular deaths in Russia [2]. Since 1980, incidence of obesity has increased by two-fold and diabetes by four-fold worldwide, according to the NCD Risk Factor Collaborators report [3,4]. Hypertension is one of the primary risk factors for heart disease and stroke. Over 875 million were hypertensives in the year 2000 and will double by the year 2025 [5]. Another factor to be considered when discussing from a global perspective, is that nearly two-thirds of individuals with CMDs live in lowand middle-income countries. On the other hand, immigrant population is increasing rapidly in several countries, because of the economic attractiveness and public infrastructure. Just look at the UAE as an example, they have more immigrants than the native Arabs. Although conventional cardiovascular risk factors such as smoking, blood pressure and total cholesterol predict risk within these ethnic groups, they do not fully account for the differences in risk, between ethnic groups, suggesting that alternative explanations might exist. We feel strongly, that there is a great need to investigate the prevalence and pattern of metabolic risks in general, identify the unique risk factors responsible for development and/or progression of these condition’s and the economic and social costs for the treatment of these diseases. All of these metabolic diseases have risen to the status of an epidemic, and cost of combating these diseases will pose, in the very near future, a great economic burden to the global community.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47414247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Nonbacterial Thrombotic Endocarditis with Embolic Vascular Events as A Manifestation of Advanced Pancreatic Cancer: A Case Report 非细菌性血栓性心内膜炎伴栓塞性血管事件作为晚期胰腺癌的表现:1例报告
Pub Date : 2018-09-24 DOI: 10.19080/jocct.2018.12.555833
F. Ribeiro
Nonbacterial thrombotic endocarditis, also known as marantic endocarditis, is a very rare complication of malignancy and other hypercoagulable states that is characterized by deposition of sterile vegetations (consisting of thrombi and fibrin) on the heart valves. The most commonly affected valves are the aortic valve, the mitral valve or both simultaneously; involvement of the right heart valves is less common. The marantic endocarditis occurs in the context of noninfectious chronic inflammatory conditions, particularly visceral malignancies, and the vegetations are much more prone to detach and embolize as compared to infectious endocarditis. Patients typically present with signs and symptoms of arterial emboli, such as ischemic cerebral events and acute coronary syndromes.
非细菌性血栓性心内膜炎,也称为溶血性心内膜炎,是恶性肿瘤和其他高凝状态的一种非常罕见的并发症,其特征是在心脏瓣膜上沉积无菌植被(由血栓和纤维蛋白组成)。最常见的瓣膜是主动脉瓣、二尖瓣或两者同时受累;累及右心瓣膜的情况较少见。侵袭性心内膜炎发生在非感染性慢性炎症的背景下,尤其是内脏恶性肿瘤,与感染性心内膜炎相比,植被更容易脱落和栓塞。患者通常表现为动脉栓塞的体征和症状,如缺血性脑事件和急性冠状动脉综合征。
{"title":"Nonbacterial Thrombotic Endocarditis with Embolic Vascular Events as A Manifestation of Advanced Pancreatic Cancer: A Case Report","authors":"F. Ribeiro","doi":"10.19080/jocct.2018.12.555833","DOIUrl":"https://doi.org/10.19080/jocct.2018.12.555833","url":null,"abstract":"Nonbacterial thrombotic endocarditis, also known as marantic endocarditis, is a very rare complication of malignancy and other hypercoagulable states that is characterized by deposition of sterile vegetations (consisting of thrombi and fibrin) on the heart valves. The most commonly affected valves are the aortic valve, the mitral valve or both simultaneously; involvement of the right heart valves is less common. The marantic endocarditis occurs in the context of noninfectious chronic inflammatory conditions, particularly visceral malignancies, and the vegetations are much more prone to detach and embolize as compared to infectious endocarditis. Patients typically present with signs and symptoms of arterial emboli, such as ischemic cerebral events and acute coronary syndromes.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44998895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining the Therapeutic Wheel of Diabetes Management 重新定义糖尿病管理的治疗车轮
Pub Date : 2018-09-17 DOI: 10.19080/jocct.2018.12.555832
M. Maladkar
Diabetes is one of the biggest global health emergencies of the 21st century. As per the International Diabetes Federation (IDF), approximately 50% of all people with diabetes live in just three countries: China (109.6 million), India (69.2 million) and the USA (29.3 million). According to ICMR-INDIAB National study, the Indian Diabetic study, around 62.4 million people had diabetes in 2011 and 77 million had prediabetes. Many Asian races show a tendency for fat deposition in the abdominal area which is known as central adiposity. Hyperinsulinemia and insulin resistance are closely associated with central adiposity. Traditionally diagnosis of diabetes was done by measuring FPG (Fasting Plasma Glucose) and OGTT (Oral Glucose Tolerance Test) is often despite several international guidelines recommending HbA1C to diagnose diabetes. However, HbA1c cannot be used as sole criteria for diagnosis of diabetes in Indian settings, but it can be used in settings where an appropriate standardization method is available.
糖尿病是21世纪最大的全球卫生突发事件之一。根据国际糖尿病联合会(IDF)的数据,大约50%的糖尿病患者生活在三个国家:中国(1.096亿)、印度(6920万)和美国(2930万)。根据ICMR-INDIAB国家研究,印度糖尿病研究,2011年约有6240万人患有糖尿病,7700万人患有前驱糖尿病。许多亚洲人的腹部有脂肪沉积的趋势,这被称为中心性肥胖。高胰岛素血症和胰岛素抵抗与中枢性肥胖密切相关。传统的糖尿病诊断是通过FPG(空腹血糖)和OGTT(口服葡萄糖耐量试验)来完成的,尽管一些国际指南推荐HbA1C来诊断糖尿病。然而,在印度,HbA1c不能作为诊断糖尿病的唯一标准,但在适当的标准化方法可用的情况下可以使用。
{"title":"Redefining the Therapeutic Wheel of Diabetes Management","authors":"M. Maladkar","doi":"10.19080/jocct.2018.12.555832","DOIUrl":"https://doi.org/10.19080/jocct.2018.12.555832","url":null,"abstract":"Diabetes is one of the biggest global health emergencies of the 21st century. As per the International Diabetes Federation (IDF), approximately 50% of all people with diabetes live in just three countries: China (109.6 million), India (69.2 million) and the USA (29.3 million). According to ICMR-INDIAB National study, the Indian Diabetic study, around 62.4 million people had diabetes in 2011 and 77 million had prediabetes. Many Asian races show a tendency for fat deposition in the abdominal area which is known as central adiposity. Hyperinsulinemia and insulin resistance are closely associated with central adiposity. Traditionally diagnosis of diabetes was done by measuring FPG (Fasting Plasma Glucose) and OGTT (Oral Glucose Tolerance Test) is often despite several international guidelines recommending HbA1C to diagnose diabetes. However, HbA1c cannot be used as sole criteria for diagnosis of diabetes in Indian settings, but it can be used in settings where an appropriate standardization method is available.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43907129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is an Antiplatelet Treatment required after an Endovascular covered stent placement for Treatment of Iatrogenically Injured non diseased Arteries? 血管内覆膜支架置入治疗医源性损伤的非病变动脉后是否需要抗血小板治疗?
Pub Date : 2018-08-27 DOI: 10.19080/JOCCT.2018.12.555830
A. Salaskar
The patient was a 50-year-old female who had past medical history of hemiglossectomy for squamous cell carcinoma of tongue and recent diagnosis of lung metastasis now presented to emergency department with respiratory failure and sepsis. During resuscitation, CVC was erroneously placed into a R-CCA. CT scan of the neck revealed a CVC entering from right side of the neck then coursing directly into the R-CCA lumen. Patient was urgently taken to IR suite. Selective angiography demonstrated patent R-CCA without any extravasation and 7 Fr CVC entering into the lumen of R-CCA and then coursing into the aortic arch. Under fluoroscopy guidance, as the CVC was slowly being retracted over a wire, a 7 mm x 2.5 cm heparin bonded Viabahn covered stent was deployed to seal the defect in the R-CCA. The stent was then inflated with same size 7 mm balloon without exerting any stretch on the vessel wall. Completion angiography demonstrated patent R-CCA without any evidence of extravasation. Based on prior CT scans, patient did not have any atherosclerotic disease in the cardiovascular system. After carotid artery stenting, patient was placed on antiplatelet medication regimen with an intention to prevent a stent thrombosis as per the common clinical practices. However, we would like to question the need for any antiplatelet treatment after an endovascular stent placement for the treatment of iatrogenically injured non-atherosclerotic disease-free vessel.
患者为50岁女性,既往因舌鳞状细胞癌行半盲切除术,近期诊断为肺转移,现因呼吸衰竭及败血症就诊于急诊科。在复苏过程中,CVC被错误地放置在R-CCA中。颈部CT扫描显示CVC从颈部右侧进入,然后直接进入R-CCA管腔。病人被紧急送往急诊室。选择性血管造影显示R-CCA未闭,无任何外渗,7fr CVC进入R-CCA管腔,然后进入主动脉弓。在透视引导下,当CVC通过导线缓慢收缩时,放置一个7 mm x 2.5 cm的肝素结合Viabahn覆盖支架来密封R-CCA中的缺陷。然后用同样大小的7毫米球囊对支架进行充气,不对血管壁施加任何拉伸。血管造影显示R-CCA专利,无任何外渗迹象。根据先前的CT扫描,患者没有任何心血管系统的动脉粥样硬化性疾病。颈动脉支架植入术后,患者按照临床惯例给予抗血小板药物治疗,目的是防止支架内血栓形成。然而,我们想质疑在血管内支架置入治疗医源性损伤的非动脉粥样硬化性无病血管后是否需要任何抗血小板治疗。
{"title":"Is an Antiplatelet Treatment required after an Endovascular covered stent placement for Treatment of Iatrogenically Injured non diseased Arteries?","authors":"A. Salaskar","doi":"10.19080/JOCCT.2018.12.555830","DOIUrl":"https://doi.org/10.19080/JOCCT.2018.12.555830","url":null,"abstract":"The patient was a 50-year-old female who had past medical history of hemiglossectomy for squamous cell carcinoma of tongue and recent diagnosis of lung metastasis now presented to emergency department with respiratory failure and sepsis. During resuscitation, CVC was erroneously placed into a R-CCA. CT scan of the neck revealed a CVC entering from right side of the neck then coursing directly into the R-CCA lumen. Patient was urgently taken to IR suite. Selective angiography demonstrated patent R-CCA without any extravasation and 7 Fr CVC entering into the lumen of R-CCA and then coursing into the aortic arch. Under fluoroscopy guidance, as the CVC was slowly being retracted over a wire, a 7 mm x 2.5 cm heparin bonded Viabahn covered stent was deployed to seal the defect in the R-CCA. The stent was then inflated with same size 7 mm balloon without exerting any stretch on the vessel wall. Completion angiography demonstrated patent R-CCA without any evidence of extravasation. Based on prior CT scans, patient did not have any atherosclerotic disease in the cardiovascular system. After carotid artery stenting, patient was placed on antiplatelet medication regimen with an intention to prevent a stent thrombosis as per the common clinical practices. However, we would like to question the need for any antiplatelet treatment after an endovascular stent placement for the treatment of iatrogenically injured non-atherosclerotic disease-free vessel.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46393085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors associated with hemorrhagic stroke in patients supported with continuous flow- LVAD 持续性LVAD患者出血性卒中的相关危险因素
Pub Date : 2018-08-27 DOI: 10.19080/JOCCT.2018.12.555831
M. Faisaluddin
{"title":"Risk factors associated with hemorrhagic stroke in patients supported with continuous flow- LVAD","authors":"M. Faisaluddin","doi":"10.19080/JOCCT.2018.12.555831","DOIUrl":"https://doi.org/10.19080/JOCCT.2018.12.555831","url":null,"abstract":"","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42269082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Dedicated Aortic Teams and Centralisation of Aortic Services, and Surgeon or Centre Specific Volumes on Outcomes of Acute Type A Aortic Dissection 专门的主动脉小组、集中的主动脉服务、外科医生或中心特定体积对急性A型主动脉夹层结局的影响
Pub Date : 2018-08-24 DOI: 10.19080/JOCCT.2018.12.555828
A. Harky
we aim the impact of dedicated aortic teams, and surgeon or centre specific volumes on outcomes of acute type A aortic dissection.
我们的目标是专门的主动脉团队和外科医生或中心特定体积对急性A型主动脉夹层结果的影响。
{"title":"The Impact of Dedicated Aortic Teams and Centralisation of Aortic Services, and Surgeon or Centre Specific Volumes on Outcomes of Acute Type A Aortic Dissection","authors":"A. Harky","doi":"10.19080/JOCCT.2018.12.555828","DOIUrl":"https://doi.org/10.19080/JOCCT.2018.12.555828","url":null,"abstract":"we aim the impact of dedicated aortic teams, and surgeon or centre specific volumes on outcomes of acute type A aortic dissection.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44579381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Role of Gene Polymorphisms in the Exacerbation and Prognosis of Chronic Obstructive Pulmonary Disease (Copd) 基因多态性在慢性阻塞性肺疾病(Copd)加重和预后中的作用
Pub Date : 2018-08-24 DOI: 10.19080/JOCCT.2018.12.555829
E. Greco
The best-documented genetic risk factor is the severe hereditary deficiency of alpha-1 antitrypsin 26, an important serum protease inhibitor. Although alpha-1 antitrypsin deficiency is only relevant for a small part of the world population, it is an example of gene interaction and environmental exposure leading to COPD [2]. Authors have confirmed that a first important step to assess the complexity of COPD is the development and validation of several multidimensional assessment indices, such as the BODE index (body mass index, FEV1, dyspnea, and exercise capacity), the ADO index (age, dyspnea, FEV1), and the DOSE index (dyspnea, FEV1, smoking status, and exacerbation frequency). All of them, however, are based on clinical and functional variables only, whereas it is well established that COPD is also a complex disease at the molecular and genetic levels; it is well known that only a percentage of smokers develop COPD, suggesting a genetically determined susceptibility for the disease. However, information at the genotype, molecular, cellular, and phenotype levels is important to understand and manage COPD [3].
证据最充分的遗传风险因素是α -1抗胰蛋白酶26(一种重要的血清蛋白酶抑制剂)的严重遗传性缺乏。虽然α -1抗胰蛋白酶缺乏症仅与世界上一小部分人口有关,但它是基因相互作用和环境暴露导致慢性阻塞性肺病的一个例子。作者已经证实,评估COPD复杂性的第一个重要步骤是开发和验证几个多维评估指标,如BODE指数(体重指数、FEV1、呼吸困难和运动能力)、ADO指数(年龄、呼吸困难、FEV1)和DOSE指数(呼吸困难、FEV1、吸烟状况和加重频率)。然而,所有这些都仅基于临床和功能变量,而众所周知,COPD在分子和遗传水平上也是一种复杂的疾病;众所周知,只有百分之一的吸烟者会患上慢性阻塞性肺病,这表明这种疾病的易感性是由基因决定的。然而,基因型、分子、细胞和表型水平的信息对于理解和管理COPD bbb非常重要。
{"title":"The Role of Gene Polymorphisms in the Exacerbation and Prognosis of Chronic Obstructive Pulmonary Disease (Copd)","authors":"E. Greco","doi":"10.19080/JOCCT.2018.12.555829","DOIUrl":"https://doi.org/10.19080/JOCCT.2018.12.555829","url":null,"abstract":"The best-documented genetic risk factor is the severe hereditary deficiency of alpha-1 antitrypsin 26, an important serum protease inhibitor. Although alpha-1 antitrypsin deficiency is only relevant for a small part of the world population, it is an example of gene interaction and environmental exposure leading to COPD [2]. Authors have confirmed that a first important step to assess the complexity of COPD is the development and validation of several multidimensional assessment indices, such as the BODE index (body mass index, FEV1, dyspnea, and exercise capacity), the ADO index (age, dyspnea, FEV1), and the DOSE index (dyspnea, FEV1, smoking status, and exacerbation frequency). All of them, however, are based on clinical and functional variables only, whereas it is well established that COPD is also a complex disease at the molecular and genetic levels; it is well known that only a percentage of smokers develop COPD, suggesting a genetically determined susceptibility for the disease. However, information at the genotype, molecular, cellular, and phenotype levels is important to understand and manage COPD [3].","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47303583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of cardiology & cardiovascular therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1